GRDN Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 30.67
- PEG ratio
- —
- P/B
- 11.69
- P/S (TTM)
- 1.66
- EV/EBITDA
- 24.64
Profitability & growth
- ROE (TTM)
- 26.6%
- Operating margin
- 8.9%
- Revenue growth YoY
- 17.4%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Guardian Pharmacy Services, Inc.
Company profileGuardian Pharmacy Services, Inc. is a premier provider of specialized pharmacy solutions tailor-made for the long-term care sector, encompassing assisted living and skilled nursing facilities. The company distinguishes itself through a commitment to personalized medication management, rigorous standards of quality and compliance, and exceptional customer service. By leveraging state-of-the-art technology and extensive pharmaceutical expertise, Guardian enhances patient outcomes while optimizing workflows for healthcare partners. With a robust operational footprint across multiple states, the…
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 GALLERIA PARKWAY SE, ATLANTA, GA
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer